サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1501114

医療診断における人工知能（AI）の世界市場

Artificial Intelligence (AI) in Medical Diagnostics
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 250 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.67円
医療診断における人工知能（AI）の世界市場
出版日: 2024年06月26日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 250 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医療診断における人工知能（AI）の世界市場は2030年までに40億米ドルに達する見込み

2023年に9億6,490万米ドルと推定される医療診断における人工知能（AI）の世界市場は、分析期間2023-2030年にCAGR 22.3%で成長し、2030年には40億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである医療診断ソフトウェアにおけるAIは、CAGR 24.1%を記録し、分析期間終了時には21億米ドルに達すると予測されます。医療診断用AIハードウェア分野の成長は、今後7年間のCAGRが17.1％と推定されます。

米国市場は2億8,930万米ドルと推定、中国はCAGR21.2％で成長予測

米国の医療診断における人工知能（AI）市場は、2023年に2億8,930万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年までの分析期間においてCAGR 21.2%で推移し、2030年までに6億6,350万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、それぞれ2023年から2030年にかけて20.2%と18.7%の成長が予測されています。欧州では、ドイツがCAGR約14.9%で成長すると予測されています。

2024年向け新レポートの特徴

  • インフルエンサーのエンゲージメント統計へのフルアクセス
  • デジタルアーカイブと"MarketGlass"リサーチプラットフォームへの無料アクセス。当社独自のMarketGlassプラットフォームは、世界中の専門家の創造性と市場知識を統合的かつコラボレーティブに提供します。当社の最新鋭ツールは、参加者のプライバシーとアイデンティティを保護しながら、世界クラスの市場展望をもたらします。本レポートに掲載されている数字、統計、市場に関する説明は、この分野の専門家やインフルエンサーによって共有された、完全に精査された洞察に基づいています。
  • リアルタイムのデータシミュレーター・ツールや特注のレポート作成機能を備えたインタラクティブなアンケートに参加できます。
  • 企業間のスマートな意見交換のためのピアコラボレーティブ・インタラクティブプラットフォームへのフルクライアントアクセス
  • 1年間の無料レポート更新
  • 主要企業の世界市場シェアを含む競合カバレッジ
  • 複数の地域にまたがる企業の市場プレゼンス分析（好調/活発/ニッチ/マイナー）
  • 専門家/インフルエンサーのインタビュー、ポッドキャスト、プレス発表、イベント基調講演のYouTubeビデオへのアクセス

2024年の世界経済に期待すること

金融引き締めとそれに伴う金利上昇による地政学的な影響と経済の不安定性が、2024年の世界経済に波乱をもたらすと思われます。中東での敵対行為や、ますます頻発する気候災害など、いくつかの要因が回復への道筋に圧力をかけ続けると思われます。リスクの一方で、ディスインフレの兆候が強まり、頑迷なインフレに対する不安が緩和され、サプライチェーンが正常化し、エネルギーコストの変動にもかかわらず物価が緩やかになるなど、いくつかのプラス材料も具体化しつつあります。インドや米国をはじめとするG21諸国の選挙は、資本の流れや投資戦略に影響を与える可能性があります。インドが世界な投資先として注目される一方で、米国を拠点とするハイテク企業は、才能と資本のダイナミックなエコシステムに後押しされ、引き続き優位を保つと思われます。シリコンバレーをはじめとするハイテク機会は、国内経済が減速しているとはいえ底堅く、規制環境も整備されていることから、高成長の可能性を求める投資家にとって引き続き魅力的です。欧州は金融引き締め政策と景気後退リスクとの戦いが続くが、英国は見通しが最も厳しく、2024年の景気後退リスクが最も高いです。中国は、政府支出と個人消費の改善に支えられた成長が期待されるもの、引き続きワイルドカードとなります。不安定な環境は、投資家にも企業にもチャンスと課題の両方をもたらすと思われます。成長への触媒としてボラティリティを受け入れるとともに、敏捷性と戦略的な先見性をもって投資判断に臨むことが、生き残りのために重要であることに変わりはないです。

調査対象企業の例（全22件）

  • Agfa Healthcare Corporation
  • Aidoc
  • AliveCor, Inc.
  • Caption Health
  • Elevance Health, Inc.
  • HeartFlow
  • Intelegain Technologies
  • Siemens Healthineers AG
  • VisualDx.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP23208

Global Artificial Intelligence (AI) in Medical Diagnostics Market to Reach $4 Billion by 2030

The global market for Artificial Intelligence (AI) in Medical Diagnostics estimated at US$964.9 Million in the year 2023, is expected to reach US$4 Billion by 2030, growing at a CAGR of 22.3% over the analysis period 2023-2030. AI in Medical Diagnostics Software, one of the segments analyzed in the report, is expected to record a 24.1% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the AI in Medical Diagnostics Hardware segment is estimated at 17.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $289.3 Million, While China is Forecast to Grow at 21.2% CAGR

The Artificial Intelligence (AI) in Medical Diagnostics market in the U.S. is estimated at US$289.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$663.5 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 20.2% and 18.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 22 Featured) -

  • Agfa Healthcare Corporation
  • Aidoc
  • AliveCor, Inc.
  • Caption Health
  • Elevance Health, Inc.
  • HeartFlow
  • Intelegain Technologies
  • Siemens Healthineers AG
  • VisualDx.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Intelligence (AI) in Medical Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI) in Medical Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 4: World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 10: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 13: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 16: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 19: World 8-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 25: World 8-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 28: World 8-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 31: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 34: World 8-Year Perspective for Pulmonology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 37: World 8-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 40: World 8-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 43: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 46: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 49: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 52: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 55: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 58: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 61: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 64: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 67: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 70: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 73: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 76: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 79: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 82: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 85: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 88: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 91: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 94: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 97: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 100: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 103: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 106: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 109: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 112: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 115: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 118: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 121: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 124: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 145: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 148: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2022 and % CAGR
    • TABLE 151: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2024 & 2030

IV. COMPETITION